Comparative antifungal efficacy of trans-cinnamaldehyde and nystatin against biofilm-forming Candida Species: Structural insights and drug susceptibility
Author:
- 29 May 2025
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 206, 107763
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide StudyJournal of Clinical Laboratory Analysis, 2024
- COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistanceMedical Mycology, 2024
- Liposome as a delivery system for the treatment of biofilm‐mediated infectionsJournal of Applied Microbiology, 2021
- Association of different Candida species with catheter‐related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm‐forming capabilitiesJournal of Clinical Laboratory Analysis, 2021
- Future therapies targeted towards eliminatingCandidabiofilms and associated infectionsExpert Review of Anti-infective Therapy, 2016
- Asarones from Acorus calamus in Combination with Azoles and Amphotericin B: A Novel Synergistic Combination to Compete Against Human Pathogenic Candida Species In VitroApplied Biochemistry and Biotechnology, 2015
- The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilmsSaudi Pharmaceutical Journal, 2015
- Antifungal activity of α-methyl trans cinnamaldehyde, its ligand and metal complexes: promising growth and ergosterol inhibitorsBioMetals, 2011
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNature Protocols, 2008
- Mechanism of action of antifungals and combination therapyJournal of the European Academy of Dermatology and Venereology, 1995